PICO

Structured summaries

Structured PICO summaries for doctors and healthcare professionals, covering population, intervention, comparison, outcomes, expert commentary, and references across diabetes, endocrinology, obesity, and cardiometabolic medicine.

PICO Diabetes & Glycaemic Control Aug 26, 2025

Does Dropout History and HbA1c Affect Future Dropout in Diabetes Patients?

PICO Cardiovascular Outcomes Aug 25, 2025

Exenatide’s Cardiovascular Benefits Extend Beyond Risk Factor Modification: EXSCEL Mediation Analysis

PICO Reproductive Endocrinology Aug 25, 2025

Can Wuziyuye Decoction Treat Type-II Diabetes with Asthenospermia?

PICO Reproductive Endocrinology Aug 24, 2025

Can Moxibustion and Low-Dose Tadalafil Improve Diabetes-Related ED?

PICO Diabetes Technology & Monitoring Aug 24, 2025

How Does Mobile Tech Affect Diabetes Views?

PICO Lipids & Statins Aug 24, 2025

Can HDL-C and Belly Fat Predict Fat Loss After Sleeve Surgery?

RCT Cardiovascular Outcomes Aug 24, 2025

Curcumin Supplementation Improves Glycemic Control and ASCVD Risk in Type 2 Diabetes: RCT

PICO Diabetes Complications Aug 24, 2025

Does NAC Help Treat Diabetic Foot Bone Infections?

PICO Diabetes Prevention Aug 24, 2025

Can Diet and Metformin Improve Prediabetes?

A crossover trial finds a moderate-FODMAP diet plus metformin lowers postprandial glucose and raises GLP-1 in prediabetes, with microbiota shifts. PICO summary and commentary.

PICO Cardiovascular Outcomes Aug 24, 2025

Is Dapagliflozin Safe in Hospitalised COVID-19 Patients With and Without Type 2 Diabetes?

A prespecified DARE-19 analysis found dapagliflozin was safe and well tolerated in hospitalised COVID-19 patients regardless of type 2 diabetes status, with no demonstrated efficacy benefit. PICO summary and expert commentary.